Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15489-15489
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Current status and future trends of the global burden of MASLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 189
Antioxidant Peptides from Monkfish Swim Bladders: Ameliorating NAFLD In Vitro by Suppressing Lipid Accumulation and Oxidative Stress via Regulating AMPK/Nrf2 Pathway
Ming‐Feng Wu, Qing-Hao Xi, Sheng Yan, et al.
Marine Drugs (2023) Vol. 21, Iss. 6, pp. 360-360
Open Access | Times Cited: 77
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé‐Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 51
Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 32
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 397-397
Open Access | Times Cited: 22
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 22
A Review of the Therapeutic Potential of Ginseng and Its Bioactive Components in Nonalcoholic Fatty Liver Disease
Liyuan Hao, Shenghao Li, Caige Li, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 83-96
Open Access | Times Cited: 2
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs
Xing Wan, Jingyuan Ma, He Bai, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 140-140
Open Access | Times Cited: 2
FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid
Kang Wang, Yuecan Zhang, Guangji Wang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 568-586
Closed Access | Times Cited: 24
Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
Hassam Ali, Muhammad Shahzil, Vishali Moond, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 61-61
Open Access | Times Cited: 12
NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 826-826
Open Access | Times Cited: 12
Subchronic oral exposure to polystyrene microplastics affects hepatic lipid metabolism, inflammation, and oxidative balance in gilthead seabream (Sparus aurata)
Filomena Del Piano, Bethanie Carney Almroth, Adriano Lama, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 279, pp. 116455-116455
Open Access | Times Cited: 10
Hericium erinaceus polysaccharides ameliorate nonalcoholic fatty liver disease via gut microbiota and tryptophan metabolism regulation in an aged laying hen model
Lianchi Wu, Zhaoying Hu, Yujie Lv, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132735-132735
Closed Access | Times Cited: 10
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 9
Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial
Soraiya Ebrahimpour‐Koujan, Amir Ali Sohrabpour, Edward L. Giovannucci, et al.
Nutrition Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis
Arnab Banerjee, Debasmita Das, Sandip Mukherjee, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112091-112091
Closed Access | Times Cited: 8
The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Yijia Song, Sutong Liu, Lihui Zhang, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 1
Platelet‐derived apoptotic vesicles ameliorate nonalcoholic fatty liver disease by regulating lipid metabolism via apolipoprotein A‐II
Yuhe Jiang, Yike Liao, Zeying Wang, et al.
Deleted Journal (2025)
Open Access | Times Cited: 1
From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH
Reda Mansour, Sherif S Abdel Mageed, Ahmed I. Abulsoud, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access | Times Cited: 1
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 1
Clinical Assessment of Common Medications for Nonalcoholic Fatty Liver Disease: A Systematic Review and Bayesian Network Meta‐Analysis
Rui Shi, Keyan Chai, Haojia Wang, et al.
Journal of Evidence-Based Medicine (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective
Nikolaus Bresgen, Melanie Kovacs, Angelika Lahnsteiner, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 912-912
Open Access | Times Cited: 17
Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease
Jiong Wang, Yucheng Jiang, Leiming Jin, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Copper homeostasis and cuproptosis in health and disease
Yunuo Yang, Jiaxuan Wu, Lisheng Wang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 7
Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6 J mice by modulating oxidative stress, inflammation and fibrosis
Di Lou, Qing Fang, Yinghao He, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116491-116491
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top